Stichting voor Patienten met Kanker aan het Spijsverteringskanaal Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2014
NCT02301286
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Stichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS)

Active Ingredients

Drugs in Phase 3 Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 3)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1